Back to Rafferty Asset Management, LLC Rafferty Asset Management, LLC

VKTXVKTX

Showing 8 of 27 quarters

Position history for Rafferty Asset Management, LLCRafferty Asset Management, LLC's holdings in Viking Therapeutics, Inc.

Yes. Rafferty Asset Management holds 99,475 shares of VKTX (Viking Therapeutics), worth $3.9M, as of its Q2 2026 13F filing. It reduced the position by 26,657 shares (-21.1%) from Q1 2026. Rafferty Asset Management has held VKTX since Q1 2023, across 14 quarterly 13F filings.

Current Value

$3.9M

Current Shares

99,475

Total Value Change

-$12.2M

Total Shares Change

-154,278

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
99,475
-21.1%
$3.9M0.0%$39.01
0
2026-Q1
Decreased
126,132
-18.6%
$4.1M0.0%$32.54
0
2025-Q4
Decreased
155,007
-22.3%
$5.5M0.0%$35.18
0
2025-Q3
Increased
199,387
+26.6%
$5.2M0.0%$26.28
33
2025-Q2
Decreased
157,499
-14.3%
$4.2M0.0%$26.50
0
2025-Q1
Decreased
183,769
-32.2%
$4.4M0.0%$24.15
0
2024-Q4
Increased
271,163
+6.9%
$10.9M0.0%$40.24
30
2024-Q3
Decreased
253,753
-24.4%
$16.1M0.1%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used